Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome-Reference-Cited by-同舟云学术

Tyrosine kinase receptor expression in chordomas: phosphorylated AKT correlates inversely with outcome

Published:2013-09 Issue:9 Volume:44 Page:1747-1755
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

de Castro MSc Carolina Vieira,Guimaraes Gustavo,Aguiar Jr Samuel,Lopes Ademar,Baiocchi Glauco,da Cunha Isabela Werneck,Campos Antonio Hugo Jose Froes Marques,Soares Fernando Augusto,Begnami Maria Dirlei

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas;Vujovic;J Pathol,2006

2. Chordoma: incidence and survival patterns in the United States, 1973-1995;McMaster;Cancer Causes Control,2001

3. Chordoma: natural history and results in 28 patients treated at a single institution;Baratti;Ann Surg Oncol,2003

4. Notochordal tumours;Mirra,2002

5. Radical radiation therapy of chordoma;Pearlman;Am J Roentgenol Rad Ther Nucl Med,1970

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of systemic therapy in advanced skull base chordomas: overview of the current state and the MD Anderson protocol;Neurosurgical Focus;2024-05

2. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors;Current Oncology Reports;2024-02-20

3. HER2-low expression in patients with advanced or metastatic solid tumors;Annals of Oncology;2023-11

4. Shedding light on emerging therapeutic targets for chordoma;Expert Opinion on Therapeutic Targets;2023-08-03

5. Association between immunohistochemical markers and tumor progression following resection of spinal chordomas: a multicenter study;Journal of Neurosurgery: Spine;2023-08-01